Skip to content

8-KAccepted Aug 19, 4:15 PM ET

Jaguar Health Reports Q2 2026 Results

JAGXJaguar Health, Inc.

Accepted (ET)

4:15 PM

Aug 19, 2026

Filed

Aug 19, 2026

Documents

13

Size

213.9 KB

Summary

Jaguar Health Reports Q2 2026 Results

Updated

What Happened
Jaguar Health, Inc. (JAGX) announced its financial results for the second quarter of 2026 in a press release issued August 19, 2026 and furnished that release on Form 8-K (Item 2.02). The company provided the press release as an exhibit to the filing.

Key Details

  • Filing date: August 19, 2026 (Form 8-K).
  • Item reported: 2.02 — Results of Operations and Financial Condition (press release announcing Q2 2026 results).
  • Exhibit furnished: 99.1 — Press Release dated August 19, 2026.
  • Interactive data: Exhibit 104 — Cover Page Interactive Data File (inline XBRL) embedded in the filing.

Why It Matters
Quarterly results contain key metrics investors use to assess company performance—revenue, net income/loss, cash position, and operating trends—which can affect stock value and investor decisions. This 8-K indicates Jaguar Health has publicly released its Q2 2026 earnings information; investors should read the furnished press release (Exhibit 99.1) for the specific financial figures and any management commentary or guidance.

AI-written summary · check the filing